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Objective. To assess the extent to which children may be falsely diagnosed as HIV-infected, using data from an antiretroviral therapy (ART) 
site in Pretoria, South Africa.
Methods. This was a retrospective patient record review of all ART-naïve children referred to Kalafong hospital’s paediatric HIV clinic 
between April 2004 and March 2010, with detailed review of those found to be HIV-uninfected.  
Results. There were 1 526 patient files analysed, with a male-to-female ratio of 1.01:1 and median age at first visit of 20 months (range 26 
days - 17.5 years).  Nearly half (n=715; 47%) of the children were aged <18 months. Fifty-one children were found to be HIV-uninfected 
after repeated diagnostic tests. Incorrect laboratory results for children aged <18 months included false-positive HIV DNA PCR tests (40), 
detectable HIV viral loads (4) and a false-positive HIV p24Ag test (1). One child above 18 months had false-positive HIV ELISA results. 
An additional 4 children were inappropriately referred after being incorrectly labelled as HIV-infected and 1 child aged <18 months was 
referred after an inappropriate diagnostic test for age was used.  In summary, 1 in every 30 (3.3%) children was discharged HIV-uninfected, 
and below age 18 months, 1 in 16 children (6.3%) had false-positive HIV virological tests.
Conclusions. Urgency in ART initiation in HIV-infected children is life-saving, especially in infants. However, HIV tests may produce 
false-positive results leading to misdiagnosis of children as HIV-infected, which has serious consequences. Meticulous checking of HIV-
positive status is of utmost importance before committing any child to lifelong ART. 
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The HIV pandemic is an ongoing threat to the well-being of children 
in sub-Saharan Africa, and in high-prevalence areas such as South 
Africa (SA), as many as 30% of births are by HIV-infected women.1 
Interventions for prevention of mother-to-child transmission 
(PMTCT) reduce the risk of transmission to infants from 35% to 
less than 5%, even in breastfeeding populations,2 but for those who 
are infected, disease progression can be rapid and it is therefore 
critical that these children are diagnosed early to ensure access to 
antiretroviral therapy (ART).3,4
In South Africa, the first public sector HIV treatment guidelines 
were released in 2004, with subsequent revision in 2010.5  A major 
policy change in the updated guideline is to initiate ART in all 
HIV-infected infants below 1 year of age, irrespective of clinical or 
immunological staging, since even asymptomatic infants have a high 
risk of morbidity and mortality if untreated.4,5
According to SA guidelines, the diagnostic protocol in children above 
18 months is similar to that of the adult protocol, using an initial 
HIV rapid or ELISA test for screening and subsequent verification 
with a second confirmatory rapid or ELISA test.5  HIV diagnosis in 
children <18 months requires HIV DNA PCR (polymerase chain 
reaction) testing, which has been shown to have excellent sensitivity 
and specificity (98.8% and 99.4%, respectively) in a research setting 
in Johannesburg (SA). However, there is little information on 
the performance of this test when applied to the clinical setting.6 
Currently the majority of HIV DNA PCR tests on infants in South 
Africa are done at primary health care facilities, using the dry blood 
spot (DBS) technique, which greatly facilitates ease of testing, even 
in small babies, using the heel-prick technique.7 The shift of care to 
primary health care level is done to broaden access to HIV-related 
care, with currently ongoing extension to also include therapeutic 
services with provision of ART.5,8
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The prevalence of HIV infection in South African children was 
reported to be 2.8% in 2010.9 This high burden of disease means 
that HIV testing of children, and subsequent access to care, has 
to be a national priority in order to reduce childhood morbidity 
and mortality. However, widespread HIV testing of children has 
potential pitfalls. This paper uses data from a single institution to 
highlight the issue of HIV-uninfected children being misdiagnosed 
as HIV-infected. 
Patients and methods
Kalafong Hospital, an urban regional hospital in the Gauteng 
province of South Africa, serves as an ART treatment centre. Records 
of all ART-naïve children referred to the hospital’s paediatric HIV 
clinic between April 2004 and March 2010 were included in this 
retrospective analysis, thus spanning the period from the start of 
the ART programme to the implementation of the updated 2010 
HIV guidelines. The Ethics Review Committee, Faculty of Health 
Sciences, University of Pretoria, approved the audit study protocol.
Patient records of all children who were referred as HIV-positive 
but who were later found to be HIV-uninfected, were reviewed in 
detail. It was standard practice in the clinic to do a confirmatory HIV 
DNA PCR test and/or quantitative HIV RNA PCR (‘viral load’) 
on all newly referred children in whom initial testing had been done 
before 18 months of age.  Further HIV testing was done because the 
second HIV DNA PCR test was negative, or the HIV viral load was 
undetectable, or the initial HIV test results were not available, or 
because the child showed no clinical and/or immunological disease 
progression. HIV diagnostic tests were done by the National Health 
Laboratory Service (NHLS).10 Between 2004 and 2009 the HIV 
DNA PCR test kits used were the AMPLICOR® HIV-1 DNA 
Test, version 1.5 (Roche Molecular Systems, Inc.) and after 2009, 
the Cobas AmpliPrep/Cobas TaqMan (‘CAP/CTM’) HIV-1 Qual 
test (Roche Molecular Systems, Inc.) was used. Additional testing 
depended on the child’s age, and entailed additional HIV DNA PCR 
and viral load tests on children aged <18 months, while laboratory-
based HIV ELISA testing was done on children aged >18 months, 
using fourth-generation HIV ELISA testing since 2005. The NHLS 
laboratories have quality assurance protocols in place,10 and all 
positive HIV ELISA tests are repeated on the same specimen using 
a different instrument, while additional HIV ELISA testing is done 
on a separate specimen if discordant results are found.
The decision to discharge a child as HIV-uninfected was made by 
the treating physician. Children without a non-reactive HIV ELISA 
result at discharge from the HIV clinic were referred to primary 
health care for HIV rapid or laboratory-based ELISA testing at 
18 months. Efforts were also made to trace all children who were 
discharged as HIV-uninfected.
Results
There were 1 526 patient files included in the study. The median age 
at first visit of the referred children was 20 months (range 26 days 
- 17.5 years) with a male-to-female ratio of 1.01:1. The majority 
(1 063 children) started ART at a median age of 29 months (range 
26 days - 17.5 years). The subgroup of children aged <18 months 
at first visit was 715 children (47%), of whom 393 children (55%) 
started ART before 18 months of age.
Fifty-one children were HIV-uninfected after diagnostic tests 
were repeated (Table 1). The main reason for incorrect HIV 
diagnosis was false-positive laboratory results found in 46 children. 
These included 40 children aged <18 months with false-positive 
HIV DNA PCR results, with another 4 children who had falsely 
detectable HIV viral loads (130 000 copies/ml, 50 000 copies/ml, 
1 600 copies/ml and 130 copies/ml, respectively), and 1 child with 
a false-positive HIV p24Ag test result. Another child had false-
positive HIV ELISA test results at age 20 months on two separate 
samples, with insufficient specimen for confirmatory testing on the 
first sample, while on the repeat sample the confirmatory test was 
non-reactive.
Of the children with false-positive virological testing, 18 (40%) 
subsequently had at least one negative HIV ELISA as well as one or 
more negative HIV virological tests (negative HIV DNA PCR test 
or undetectable HIV viral load). Another 16 children (36%) were 
discharged after two negative virological tests and 11 children (24%) 
had three or more negative virological tests.
In the review of the medical files, the children considered uninfected 
had adequate documentation of appropriate confirmatory tests and 
none of the discharges was deemed to have been inappropriate. For 
patients discharged below 18 months of age, caregivers were advised 
to have a confirmatory HIV rapid or ELISA test done at a primary 
health care facility at 18 months. None of the discharged children 
was subsequently referred back as HIV-infected. Telephonic follow-
up was done in August 2010 and 20 children were traceable, and 
reported to have remained uninfected.
Healthcare workers had inappropriately referred a further 5 patients 
for HIV-related care, of whom 4 children had incorrectly been 
labelled as HIV-infected without diagnostic proof. One child was 
referred as having a positive HIV DNA PCR result, although the test 
referred to had a negative result. Another child was referred although 
the HIV PCR result was equivocal, and on repeat the HIV DNA 
PCR was negative. One child from a children’s home was referred 
for HIV care, implying that the child was HIV-infected, but the 
child was uninfected on testing. Another orphaned child with severe 
malnutrition was referred as HIV-infected and for ART initiation, 
but subsequently tested HIV-negative. In 1 child below 18 months 
an inappropriate diagnostic test for age was used, as he was referred 
as HIV-infected after a positive HIV ELISA test.
Children referred with false-positive laboratory results had a 
median age of 4 months (range 1 - 35 months) and a median 
number of 3 patient visits (range 1 - 11 visits), while the 5 children 
incorrectly referred for other reasons had a median age of 9 
months (range 4 - 73 months), with a median of 2 visits (range 
1 - 4 visits). During the 6-year period, misdiagnosis of HIV in 
children resulted in 193 added patient visits at the HIV clinic, 
Table 1.  Summary of cases misdiagnosed as HIV-infected
Subtotal Total
False-positive laboratory results 46
•	 False-positive HIV virological tests
•	 False-positive HIV DNA PCR test 
results
40
•	 Falsely detectable HIV viral load 
results
4
•	 False-positive HIV p24Ag test result 1
•	 False-positive HIV antibody test
•	 False-positive HIV ELISA test result 1*
Incorrect referrals 5
•	 Referral after incorrect labelling as HIV-
infected
4
•	 Age-inappropriate HIV test done† 1
Total 51
*Insufficient specimen for confirmatory ELISA on first sample; non-reactive 
confirmatory ELISA on second sample.
†HIV ELISA test done as diagnostic test in age group <18 months.
74        SAJCH  AUGUST 2012  Vol. 6  No. 3
ARTICLE
with further HIV testing done to confirm their 
HIV-negative status. None of the children 
described in this study had inadvertendly been 
started on ART, due to the timely identification 
of the misdiagnosis.
Of the 46 children with false-positive HIV tests, 
33 had documented PMTCT interventions, while 
5 children had no PMTCT and for 8 children 
the information was not recorded. According 
to World Health Organization (WHO) HIV 
clinical staging done at the HIV clinic, 36 
(78%) were asymptomatic or had a minor illness 
(stages 1 and 2), while 9 (20%) were classified 
as symptomatic (with stage 3 or 4 disease), and 
1 child (2%) was not staged. WHO stage 3 
events in the children included oral candidiasis 
outside the neonatal period (4), malnutrition (3), 
pulmonary tuberculosis (2) and history of severe 
infection (meningitis) (1). The child classified 
as WHO stage 4 had been hospitalised at the 
age of 5 months with severe pneumonia and a 
presumptive diagnosis of Pneumocystis jirovecii 
pneumonia.
In the context of all 1 526 reviewed HIV clinic 
patient files, the subsequent discharge of the 51 
reported children means that 1 in every 30 (3.3%) referred children 
was later discharged as HIV-uninfected. In the age group below 18 
months, 1 in every 16 children (6.3%) had been misdiagnosed as 
HIV-infected on a false-positive HIV virological test.
Discussion
HIV disease in children has become a chronic treatable condition, 
and many lives can be saved by early disease detection with 
subsequent access to ART. This urgency is especially important in the 
first year of life, with proven survival benefit with immediate ART 
initiation.4 Both South African (2010)5 and WHO guidelines11 call 
for initiation of ART for all HIV-infected childen diagnosed before 
the age of 12 months, even if asymptomatic. For those diagnosed in 
the second year of life, WHO guidelines again recommend treatment 
of all infected children, while South African guidelines recommend 
treatment based on clinical disease progression or CD4 count/ 
percentage. Widespread testing of children has its pitfalls, however, 
as HIV tests may produce false-positive results and misdiagnosis of 
children as HIV-infected has serious consequences.
A limitation to this study is that it is a clinic-based retrospective 
audit, and that possibly not all who were misdiagnosed as being HIV-
infected were identified. On review of the medical records, none of 
the discharges as HIV-uninfected was deemed inappropriate. We do 
not have access to all follow-up test results, but all of those who were 
known to have had follow-up testing were confirmed uninfected and 
no child was subsequently referred back with HIV disease to the 
Kalafong ART site.
In the South African public sector, ART provision is moving from 
dedicated ART clinics to primary health care facilities in order to 
broaden access to care.5 In the context of this study, children were 
referred for care at the ART site after HIV diagnosis. We found that 
incorrect referrals included children who had been wrongly labelled 
as HIV-infected or in whom age-inappropriate HIV testing had 
been done. It is of utmost importance that diagnostic algorithms are 
followed by healthcare workers and that all preceding laboratory test 
results which prove HIV infection are meticulously checked before 
initiation of ART.
In this study, false-positive test results were 
the most frequent reason for misdiagnosis of 
HIV infection; this occurred mainly in young, 
asymptomatic children who required HIV DNA 
PCR testing for PMTCT programme follow-
up. The HIV DNA PCR test has been shown in 
South Africa to have an excellent sensitivity and 
specificity, achieved within a research environment 
with adequate staff training and sufficient staffing 
levels.6 Our results show that 6.3% of children 
referred below age 18 months were incorrectly 
diagnosed as HIV-infected due to false-positive 
virological test results. Everyday clinical use of 
HIV tests in large-scale ART programmes, as 
is the case in South Africa, within the context 
of scarce human resources, increases the risk of 
incorrect specimen labelling and handling errors 
at clinics and laboratories. False-positive test 
results can also occur due to laboratory errors 
through specimen contamination and inadequate 
quality control.6
Alarmingly, one-fifth (20%) of children falsely 
diagnosed as HIV-infected in this study were 
staged as having moderate to severe (WHO stages 
3 or 4) HIV disease. Incorrectly diagnosing HIV 
disease implies misdiagnosis of the true disease, 
a reminder to clinicians that other conditions, like tuberculosis and 
malnutrition, may mimick HIV disease in children.
The study period spanned from the start of ART availability 
and HIV DNA PCR testing in South Africa’s public sector in 
2004 to the implementation of the updated paediatric treatment 
guidelines in 2010. New national PMTCT guidelines were also 
released during 2010, intensifying interventions to reduce HIV 
transmission to children.12 As the PMTCT programme improves 
and HIV prevalence in children subsequently decreases, the positive 
predictive value of the HIV DNA PCR, as with any test, declines, 
and even with the excellent specificity, there is an increased risk 
of false-positive test results.13 The choice of test kits with different 
specificities can, in this context, have a profound effect on the 
clinical outcome achieved within programmatic testing. During 
our study the majority of HIV DNA PCR tests were done using 
the AMPLICOR HIV-1 DNA test, while during the last year of 
study the Cobas AmpliPrep/Cobas TaqMan HIV-1 Qual test was 
introduced, due to its advantages of a shorter turn-around time 
and being less labour intensive. The report from Maritz et al.14 
comparing the Amplicor and CAP/CTM tests is concerning due to 
reported lower specificity of the CAP/CTM test, as any decrease in 
test specificity would further greatly decrease the positive predictive 
value of any one positive HIV DNA PCR test.13
One major change in the SA paediatric guidelines (2010) is the 
immediate initiation of ART in all HIV-infected children diagnosed 
before age 1 year, meaning that even asymptomatic infants are eligible 
for ART.5 Clinical staff can therefore no longer depend on the 
congruence of laboratory result and clinical picture in asymptomatic 
patients, with diagnosis of HIV infection thus relying fully on positive 
laboratory testing.13 The guidelines recommend that HIV testing in 
infants is done by HIV DNA PCR testing, with an HIV RNA viral 
load used as confirmatory test, using a cut-off of at least 10 000 copies/
ml (log
10
4) for diagnostic purposes.5 In sub-Saharan Africa most HIV-
exposed children stay far from health care centres with paediatric HIV 
expertise, and clinical staff may interpret low-level positive RNA viral 
loads as proof of HIV-positive status of an uninfected child, if training 
on the strengths and limitations of laboratory tests is neglected.15 
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This may become clinically more relevant within the context of ART 
services expanding into primary health care facilities.5
To minimise harm which may occur through misdiagnosis of 
HIV infection in HIV-exposed children who, due to PMTCT 
interventions, are increasingly less likely to be HIV-infected, the 
following recommendations are made: 
•	 training of healthcare workers on HIV diagnostic guidelines and 
use of HIV diagnostic tests in children
•	 review of HIV testing algorithms within the context of changing 
circumstances, including the shifting paediatric HIV epidemic and 
changing ART guidelines
•	 adequate clinical notes and clearly written referrals between 
healthcare providers as standard of care 
•	 healthcare facilities to review procedures during venepuncture to 
minimise risk of mislabelling of blood specimens
•	 continuous quality assurance in laboratories with detailed 
prevention of contamination
•	 meticulous checking of laboratory results within clinical practice
•	 confirming positive test results, especially in asymptomatic 
patients.  In the South African context this would, under current 
guidelines, include confirming a positive HIV DNA PCR test 
with an HIV viral load of >log104 before conclusively diagnosing a 
child as HIV-infected. Furthermore, if there is any doubt about the 
diagnosis of HIV infection, especially in an asymptomatic infant, 
the HIV DNA PCR test should be repeated.5,6,13
In conclusion, ART initiation in an HIV-infected child is life-
saving, and should not be unduly postponed. Within the context 
of decentralisation of ART services, HIV testing algorithms need 
to be robust in balancing the risks of over- and under-diagnosis of 
the disease, especially in infants who require HIV virological testing. 
Staff training on the strengths and limitations of laboratory tests is 
vital, as clinical judgement is paramount in interpreting any positive 
laboratory result, even if the test is known to have an excellent 
sensitivity and specificity, as misdiagnosing an HIV-uninfected child 
as infected may mean committal to lifelong ART. 
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